Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Semaglutide drugs, like Ozempic and Wegovy, have helped millions of Americans lose weight, reduce cravings and better manage ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

Another theory is that GLP-1s (glucagon-like peptide-1 receptor agonists) — the class of medication semaglutide belongs to — can cause nausea. Why? These drugs activate GLP-1 receptors in the ...